A client at the mental health center reports difficulty concentrating at work, feeling very tired during the day, and sleeping 4 to 5 hours at night. To further assess for depression, which question is most important for the practical nurse (PN) to ask?

Limited abduction of the legs in a newborn can be a sign of developmental dysplasia of the hip (DDH), a condition in which the hip joint is not properly formed. The practical nurse (PN) should notify the healthcare provider of this finding so that further assessment and appropriate intervention can be initiated.

Performing range of motion to the joint (A) is not appropriate without a healthcare provider's order. Continuing care as if this is a normal finding (B) is not appropriate because limited abduction of the legs in a newborn can be a sign of DDH. While documenting the finding in the record (D) is important, notifying the healthcare provider is the most important action for the PN to take next.

Rationale:

A. Increased appetite is not a direct therapeutic indicator of baclofen efficacy. While improved comfort from muscle relaxation might indirectly support better intake, the drug does not possess orexigenic properties. Nutritional status is monitored in cerebral palsy patients, but it remains unrelated to the specific pharmacological mechanism of this skeletal muscle relaxant.

B. Sufficient urinary output is a vital assessment of general physiological and renal function, yet it is not the target of baclofen therapy. Baclofen acts primarily on the central nervous system to inhibit monosynaptic and polysynaptic reflexes at the spinal level. Urinary monitoring ensures adequate drug clearance, but output levels do not reflect the medication's clinical success.

C. Fewer temper outbursts might suggest a reduction in physical discomfort, but baclofen is not an antianxiety or antipsychotic medication. Cerebral palsy may involve behavioral challenges, but the primary goal of this therapy is physical rather than psychological. Behavioral changes are subjective and do not provide a scientific measure of the drug’s specific muscle-relaxing influence.

D. Decreased muscular spasticity is the primary therapeutic goal for a client with cerebral palsy receiving baclofen. This medication functions as a gamma-aminobutyric acid (GABA) analogue, effectively reducing the transmission of excitatory signals that cause hypertonia and involuntary muscle contractions. A reduction in resistance to passive movement confirms that the drug is achieving its intended neuromuscular effect.